Vilon
unknown riskAlso: Lys-Glu · KE dipeptide
Vilon is a synthetic dipeptide (Lys-Glu) from the Khavinson bioregulator series representing one of the simplest bioactive peptides under investigation. Despite its minimal structure, studies claim broad immunomodulatory and anti-aging effects.
Reported Benefits
Immune Modulation
Russian studies show restoration of T-cell counts and NK activity in aging.
Longevity
Animal studies report lifespan extension comparable to larger bioregulator peptides.
Mechanism of Action
Vilon is proposed to penetrate cell nuclei and regulate chromatin structure similarly to other bioregulator dipeptides. Despite containing only two amino acids (Lys-Glu), it may interact with transcription factor binding sites to modulate immune gene expression.
Key Clinical Studies
Khavinson VKh et al. (2008)
animal · Aged animals
Immune restoration and lifespan extension with vilon
Overview
Vilon is the simplest peptide in the Khavinson bioregulator series — just two amino acids. The hypothesis that such a minimal structure can exert specific gene regulatory effects in immune tissue is extraordinary and requires extraordinary evidence. The current evidence base, while consistent in direction, does not yet meet that standard.
Dipeptide Bioactivity
The field of bioactive dipeptides and tripeptides is scientifically legitimate — many food-derived peptides with two or three amino acids have documented biological activities. The question for vilon is whether its specific immunomodulatory claims can be validated in rigorous, independently replicated trials.
Comparative Context
Within the bioregulator series, vilon targets the immune system similarly to thymalin and thymosin alpha-1 but represents the minimalist extreme. Whether this minimalism reduces or preserves activity compared to larger preparations is unclear.
Regulatory Status
Research OnlyRussian bioregulator dipeptide; no FDA/EMA approval
Safety Profile
Side Effects
- •Injection site reactions (mild)
Contraindications
- •Active autoimmune disease
Drug Interactions
- •Immunosuppressants
Primary Uses
Related Peptides
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe Vilon?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →